Federal Register Notice: FDA and the Centers for Medicare and Medicaid Services have decided to extend the “Pilot Program for Parallel Review of Medical Products” as currently designed for an additional period of two years from the date of publication of this notice.Once a representative group of participants have completed the pilot process the agencies will formally evaluate the program for best practices and will announce any future revisions and/or enhancements in a future Federal Register notice. To view this notice, click here.